Logo
Halalify
Sign In

Is Concord Biotech Ltd (CONCORDBIO) Halal and Shariah Compliant?

CONCORDBIO
Healthcare
Pharmaceuticals

Current Price

₹1,346
+0.53%
About Company

Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. **This ethica

Pros
  • Company has reduced debt.
  • Company is almost debt free.
Cons
  • The company has delivered a poor sales growth of 11.3% over past five years.

Analysis Locked

Create a free account to view the complete Halal status, detailed breakdown, purification ratio, and trusted third-party references for Concord Biotech Ltd.

Shariah Compliance Analysis of Concord Biotech Ltd

When navigating the Indian stock market, ethical investors constantly seek to align their portfolios with Islamic finance principles. A frequent question we receive is whether Concord Biotech Ltd (CONCORDBIO) is Halal and Shariah compliant. To accurately determine the Shariah compliance status of Concord Biotech Ltd, we must conduct a comprehensive quantitative and qualitative analysis of both its core business operations and its underlying financial health.

Business Sector Screening for CONCORDBIO

The very first and most critical step in Halal stock screening is ensuring that the primary business activities of Concord Biotech Ltd do not violate Islamic law. Companies heavily involved in prohibited (Haraam) sectors like conventional banking, alcohol, gambling, and adult entertainment are strictly excluded. If Concord Biotech Ltd derives its core revenue from permissible (Halal) activities, it successfully advances to the financial ratio analysis phase.

Financial Ratio Analysis

Even if a prominent company like Concord Biotech Ltd operates entirely within a Halal sector, it must still pass strict financial screens to guarantee its corporate practices align with Shariah principles.

  • Debt to Total Assets: The interest-bearing debt of Concord Biotech Ltd must not exceed the universally accepted threshold (typically 30% or 33%).
  • Illiquid to Total Assets: Concord Biotech Ltd must maintain a sufficient percentage of tangible, illiquid assets in its portfolio.
  • Impermissible Income: Any incidental non-compliant revenue (like interest) must strictly remain below 5% of total gross revenue.

Dividend Purification for Concord Biotech Ltd

If Concord Biotech Ltd (CONCORDBIO) passes both the sector screens and strict financial tests, it is classified as a Halal stock. However, any incidental impermissible income earned by the company must be cleansed. Investors holding CONCORDBIO are required to calculate their dividend purification ratio and donate that exact portion to charity, with no expectation of spiritual reward (Sawab), purifying their Halal earnings.

By utilizing our advanced Halal stock screener platform, you can effortlessly track the live Shariah compliance status of Concord Biotech Ltd (CONCORDBIO), view historical compliance trends, and access precise dividend purification calculations. Make informed, ethical investment decisions with confidence.

⚠️ Disclaimer & Research Notice: This analysis is for informational and reference purposes only. It is not financial advice, and we are not responsible for any financial losses or damages incurred. Always do your own research (DYOR) and consult with a qualified Shariah advisor or financial planner before making any investment decisions.